Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Universal Biosensors has commercialized several diagnostic products based on its proprietary electrochemical biosensor platform. These include the Sentia™ Wine Analyzer for oenology applications; Xprecia Prime™ and Xprecia Stride® for blood coagulation/INR testing; PETRACKR® for veterinary blood glucose monitoring; and services through Hemostasis Reference Laboratory. The company’s products are FDA-cleared or CE-marked where applicable and are actively marketed globally. No therapeutics or clinical trial results apply as the company focuses on diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Universal Biosensors.